SpiderRock Advisors’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$145K Buy
+26,965
New +$145K ﹤0.01% 605